Verrix to Exhibit at International Association of Healthcare Central Service Material Management 2019 Annual Conference

    0
    341
    Reading Time: 2 minutes

    Experts to Discuss the Future of Sterilization Monitoring Using
    Technology Developed by NASA’s Jet Propulsion Laboratory

    –(BUSINESS WIRE)–Verrix:

    WHEN:   Sunday, April 28, 2019, to Wednesday, May 1, 2019
     
    WHAT: Verrix will be exhibiting at the IAHCSMM 2019 Annual Conference &
    Expo to discuss critical needs in sterilization monitoring and
    engage with champions in the sterile processing field to explore the
    future of sterile processing.
     
    WHY: Inadequately sterilized surgical instruments are a major contributor
    to infection outbreaks. Biological indicator (BI) systems are used
    to monitor the lethality of sterilization cycles and detect failed
    cycles, providing greater confidence that surgical instruments are
    free from contamination. Delays and inaccuracies in the
    sterilization confirmation process can lead to unwarranted risk and
    operational disruption. Verrix is taking a new approach to develop
    solutions that deliver BI results with unprecedented speed and
    accuracy and eliminate common causes of error.
     
    HIGHLIGHTS:
    • Meet Adrian Ponce, Ph.D., Verrix Founder/Inventor and NASA Jet
      Propulsion Laboratory Scientist, on Monday, April 29, 1–5 p.m.
      PDT.
    • Interview the Verrix team of scientists and commercial partners
      working to develop solutions for accurate and rapid
      sterilization confirmation.
    • Verrix to hold drawing for conference attendees to win one of
      three $500 education vouchers (valid for use on accredited
      educational expenses).
     
    WHERE:

    Booth #821 at the Anaheim Marriott and Convention Center, 800 West
    Katella Ave., Anaheim, CA 92802.

     

    About Verrix

    Verrix is a San Clemente, Calif.-based medical device company that is
    using the most advanced technologies to help protect patients from
    healthcare-associated infections. The foundational sterility assurance
    technology, originally discovered at NASA’s Jet Propulsion Laboratory,
    integrates cutting-edge optical physics, chemistry spectroscopy, and
    molecular biology. Based on scientific expertise and close partnerships
    with healthcare professionals, Verrix is developing market-changing
    solutions for sterility assurance, environmental monitoring, and
    infection control. Visit www.verrix.com
    for more information.

    Contacts

    Media Contacts
    Andrea Sampson, Sullivan & Sampson PR
    [email protected],
    714/374-6174

    Erin Manning, Vice President, Marketing, Verrix
    [email protected],
    949/668-1229